Ze Bo Hu

614 total citations
19 papers, 464 citations indexed

About

Ze Bo Hu is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Ze Bo Hu has authored 19 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Ze Bo Hu's work include Renal Diseases and Glomerulopathies (6 papers), Extracellular vesicles in disease (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Ze Bo Hu is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Extracellular vesicles in disease (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Ze Bo Hu collaborates with scholars based in China, United Kingdom and Bangladesh. Ze Bo Hu's co-authors include Kun Ling, Bi Cheng Liu, Jian Lü, Xiong Z. Ruan, Yu Wu, Pei Pei Chen, Chen Lu, Gui Hua Wang, Yang Zhang and Yang Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of the American Society of Nephrology.

In The Last Decade

Ze Bo Hu

19 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ze Bo Hu China 12 181 139 97 84 69 19 464
Yinyin Chen China 15 225 1.2× 100 0.7× 88 0.9× 76 0.9× 30 0.4× 33 563
Beatriz Santamaría Spain 14 202 1.1× 180 1.3× 61 0.6× 106 1.3× 52 0.8× 24 574
Daniel Mar United States 11 280 1.5× 95 0.7× 61 0.6× 69 0.8× 71 1.0× 17 493
Gloria Michelle Ducasa United States 8 129 0.7× 128 0.9× 78 0.8× 76 0.9× 56 0.8× 15 364
Yanlin Yu China 11 187 1.0× 242 1.7× 57 0.6× 60 0.7× 41 0.6× 15 550
Min W. Spencer United States 7 96 0.5× 130 0.9× 66 0.7× 71 0.8× 62 0.9× 8 388
Atsuhito Tone Japan 12 129 0.7× 195 1.4× 58 0.6× 66 0.8× 132 1.9× 30 512
Freddy Romero United States 10 117 0.6× 114 0.8× 54 0.6× 86 1.0× 47 0.7× 18 565
Feng Bai China 14 226 1.2× 98 0.7× 84 0.9× 67 0.8× 144 2.1× 32 609

Countries citing papers authored by Ze Bo Hu

Since Specialization
Citations

This map shows the geographic impact of Ze Bo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Bo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Bo Hu more than expected).

Fields of papers citing papers by Ze Bo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze Bo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Bo Hu. The network helps show where Ze Bo Hu may publish in the future.

Co-authorship network of co-authors of Ze Bo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Ze Bo Hu. A scholar is included among the top collaborators of Ze Bo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze Bo Hu. Ze Bo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yuanfang, et al.. (2025). Dietary broccoli alleviates intestinal inflammation in mice by mitigating ferroptosis induced through activating AhR. Journal of Functional Foods. 127. 106770–106770. 1 indexed citations
2.
Hu, Ze Bo, et al.. (2024). Transient and elusive intermediate states in self‐assembly processes: An overview. SHILAP Revista de lepidopterología. 2(2). 12 indexed citations
3.
Hu, Ze Bo, Jian Lü, Pei Pei Chen, et al.. (2020). Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis. Theranostics. 10(6). 2803–2816. 77 indexed citations
4.
Ling, Kun, Liang Liu, Yang Zhang, et al.. (2019). Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway. International Urology and Nephrology. 51(3). 551–558. 7 indexed citations
5.
Lü, Jian, et al.. (2019). Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus. BMC Nephrology. 20(1). 303–303. 23 indexed citations
6.
Ling, Kun, Ze Bo Hu, Yang Zhang, et al.. (2018). Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease. BMC Nephrology. 19(1). 192–192. 16 indexed citations
7.
Wang, Gui Hua, Jian Lü, Kun Ling, et al.. (2018). The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy. Journal of Atherosclerosis and Thrombosis. 26(6). 538–546. 9 indexed citations
8.
Wang, Gui Hua, Kun Ling, Yang Zhang, et al.. (2018). Caspase 3/ROCK1 pathway mediates high glucose-induced platelet microparticles shedding. Biochemical and Biophysical Research Communications. 509(2). 596–602. 9 indexed citations
9.
Ling, Kun, Yu Wu, Yang Zhang, et al.. (2018). Activation of the CXCL16/CXCR6 pathway promotes lipid deposition in fatty livers of apolipoprotein E knockout mice and HepG2 cells.. PubMed. 10(6). 1802–1816. 18 indexed citations
10.
Zhang, Yang, Kun Ling, Gui Hua Wang, et al.. (2018). Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy. Journal of the American Society of Nephrology. 29(11). 2671–2695. 76 indexed citations
11.
Ling, Kun, Ze Bo Hu, Yang Zhang, et al.. (2017). MP614LIPOPROTEIN A CONTRIBUTES TO THE PROGRESSION OF ATHEROSCLEROSIS IN PATIENTS WITH END-STAGE RENAL DISEASE. Nephrology Dialysis Transplantation. 32(suppl_3). iii659–iii660. 1 indexed citations
12.
Hu, Ze Bo, Yan Chen, Min Gao, et al.. (2016). Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease. International Journal of Medical Sciences. 13(11). 858–867. 26 indexed citations
13.
Wu, Yu, Kun Liu, Yang Zhang, et al.. (2016). Lipid disorder and intrahepatic renin–angiotensin system activation synergistically contribute to non‐alcoholic fatty liver disease. Liver International. 36(10). 1525–1534. 39 indexed citations
14.
Hu, Ze Bo, et al.. (2016). SP338ACTIVATION OF CXCL16/CXCR6 PATHWAY BY INFLAMMATION ACCELERATES THE PROGRESSION OF DIABETIC NEPHROPATHY. Nephrology Dialysis Transplantation. 31(suppl_1). i203–i203. 1 indexed citations
15.
Zhang, Yang, Kun Ling, Jing Liu, et al.. (2015). Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy. Acta Diabetologica. 52(6). 1045–1056. 48 indexed citations
16.
Ling, Kun, Yang Zhang, Jing Liu, et al.. (2015). Inflammatory stress induces lipid accumulation in multi-organs of <italic>db</italic>/<italic>db</italic> mice. Acta Biochimica et Biophysica Sinica. 47(10). 767–774. 8 indexed citations
17.
Liu, Jing, Kun Ling, Yang Zhang, et al.. (2015). Activation of mTORC1 disrupted LDL receptor pathway: A potential new mechanism for the progression of non-alcoholic fatty liver disease. The International Journal of Biochemistry & Cell Biology. 61. 8–19. 42 indexed citations
18.
Zhang, Yang, Kun Ling, Jing Liu, et al.. (2015). Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. American Journal of Physiology-Endocrinology and Metabolism. 308(12). E1140–E1148. 35 indexed citations
19.
Ling, Kun, Yang Zhang, Jing Liu, et al.. (2014). Establishment of an Inflamed Animal Model of Diabetic Nephropathy. International Journal of Biological Sciences. 10(2). 149–159. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026